There are some risks to consider before jumping on the bandwagon.Once again, the technology sector drove much of the market's gains this year. The healthcare industry, on the other hand, has been a bit of a laggard.However, there have been notable standouts among medically focused stocks. The list of strong performers includes CRISPR Therapeutics (CRSP +0.44%), a biotech company, and HCA Healthcare (HCA +0.03%), a leading hospital chain. They have outperformed the S&P 500, (^GSPC +0.32%) rising by 44% and 5 ...